ERYTECH to Participate in the Citi 16th Annual BioPharma Conference

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced its participation in the Citi 16th Annual BioPharma Conference and invites investors to join virtually via one-on-one meetings. 

Menu